期刊文献+

Aberrant expression of alternative isoforms of transcription factors in hepatocellular carcinoma 被引量:3

Aberrant expression of alternative isoforms of transcription factors in hepatocellular carcinoma
下载PDF
导出
摘要 Hepatocellular carcinoma(HCC) is one of the most prevalent malignancies worldwide and the second leading cause of death among all cancer types. Deregulation of the networks of tissue-specific transcription factors(TFs) observed in HCC leads to profound changes in the hepatic transcriptional program that facilitates tumor progression. In addition, recent reports suggest that substantial aberrations in the production of TF isoforms occur in HCC. In vitro experiments have identified distinct isoform-specific regulatory functions and related biological effects of liver-specific TFs that are implicated in carcinogenesis, which may be relevant for tumor progression and clinical outcome. This study reviews available data on the expression of isoforms of liver-specific and ubiquitous TFs in the liver and HCC and their effects, including HNF4α, C/EBPs, p73 and TCF7 L2, and indicates that assessment of the ratio of isoforms and targeting specific TF variants may be beneficial for the prognosis and treatment of HCC. Hepatocellular carcinoma(HCC) is one of the most prevalent malignancies worldwide and the second leading cause of death among all cancer types. Deregulation of the networks of tissue-specific transcription factors(TFs) observed in HCC leads to profound changes in the hepatic transcriptional program that facilitates tumor progression. In addition, recent reports suggest that substantial aberrations in the production of TF isoforms occur in HCC. In vitro experiments have identified distinct isoform-specific regulatory functions and related biological effects of liver-specific TFs that are implicated in carcinogenesis, which may be relevant for tumor progression and clinical outcome. This study reviews available data on the expression of isoforms of liver-specific and ubiquitous TFs in the liver and HCC and their effects, including HNF4α, C/EBPs, p73 and TCF7 L2, and indicates that assessment of the ratio of isoforms and targeting specific TF variants may be beneficial for the prognosis and treatment of HCC.
出处 《World Journal of Hepatology》 CAS 2018年第10期645-661,共17页 世界肝病学杂志(英文版)(电子版)
基金 Supported by Russian Foundation for Basic Research,contract No.18-34-00816\18
关键词 ALTERNATIVE ISOFORMS TRANSCRIPTION factors Hepatocellular carcinoma ALTERNATIVE SPLICING Hepatic differentiation PERSONALIZED treatment Alternative isoforms Transcription factors Hepatocellular carcinoma Alternative splicing Hepatic differentiation Personalized treatment
  • 相关文献

参考文献2

二级参考文献43

  • 1Yue-Ye Huang,Aaron M Gusdon,Shen Qu.Cross-talk between the thyroid and liver:A new target for nonalcoholic fatty liver disease treatment[J].World Journal of Gastroenterology,2013,19(45):8238-8246. 被引量:3
  • 2Birkenmeier EH, Gwynn B, Howard S, et al. Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein. Genes Dev 1989; 3:1146-1156.
  • 3Xanthopoulos KG, Mirkovitch J, Decker T, Kuo CF, Darnell JE Jr. Cell-specific transcriptional control of the mouse DNA-binding protein mC/EBP. Proc Natl Acad Sci USA 1989; 86:4117-4121.
  • 4Darlington G J, Wang N, Hanson RW. C/EBP alpha: a critical regulator of genes governing integrative metabolic processes.Curr Opin Genet Dev 1995; 5:565-570.
  • 5Watkins P J, Condreay JP, Huber BE, Jacobs S J, Adams DJ.Impaired proliferation and tumorigenicity induced by CCAAT/enhancer-binding protein. Cancer Res 1996; 56:1063-1067.
  • 6Freytag SO, Geddes TJ. Reciprocal regulation of adipogenesis by Myc and C/EBP alpha. Science 1992; 256:379-382.
  • 7Hendricks-Taylor LR, Darlington GJ. Inhibition of cell proliferation by C/EBP alpha occurs in many cell types, does not require the presence of p53 or Rb, and is not affected by large T-antigen.Nucleic Acids Res 1995; 23:4726-4733.
  • 8Timchenko NA, Harris TE, Wilde M, et al. CCAAT/enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice. Mol Cell Biol 1997; 17:7353-7361.
  • 9Timchenko NA, Wilde M, Darlington GJ. C/EBPalpha regulates formation of S-phase-specific E2F-p 107 complexes in livers of newborn mice. Mol Cell Biol 1999; 19:2936-2945.
  • 10Timchenko NA, Wilde M, Iakova P, Albrecht JH, Darlington GJ.E2F/p107 and E2F/p130 complexes are regulated by C/EBPalpha in 3T3-L 1 adipocytes. Nucleic Acids Res 1999; 27:3621-3630.

共引文献12

同被引文献16

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部